From Clinical Care Options (CCO), new data in managing axial psoriatic arthritis and axial spondyloarthritis from EULAR 2021
Video from Clinical Care Options (CCO) featuring expert insights into the whole-patient approach including treatment selection, common comorbidities, and coordination of care for patients with PsO/PsA.
Clinical Care Options (CCO) faculty Dr. April Armstrong and Dr. Philip Mease discuss problem of access to dermatologists and rheumatologists experienced by patients with PsO and PsA and potential solutions
C-OPTIMISE: Withdrawal of CZP in patients with axSpA associated with increased ASDAS, BASDAI, CRP, fecal calprotectin in absence of flares. From EULAR 2021 as reported by Clinical Care Options (CCO)